Caricamento...
Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
BACKGROUND: On June 30, 2020, the WHO reported over 10 millions of COVID-19 cases worldwide with over half a million deaths. In severe cases the disease progresses into an Acute Respiratory Distress Syndrome (ARDS), which in turn depends on an overproduction of cytokines (IL-6, TNFα, IL-12, IL-8, CC...
Salvato in:
| Pubblicato in: | Clin Mol Allergy |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7480203/ https://ncbi.nlm.nih.gov/pubmed/32922210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-020-00132-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|